US Stock MarketDetailed Quotes

VOR Vor Biopharma

Watchlist
  • 0.952
  • +0.007+0.72%
Close Jul 25 16:00 ET
64.96MMarket Cap-537P/E (TTM)

Vor Biopharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-25.54%-30.47M
-17.79%-100.29M
-30.96%-24.03M
-47.59%-27.9M
3.57%-24.1M
-5.96%-24.27M
-23.14%-85.14M
-4.32%-18.35M
-8.99%-18.9M
-50.87%-24.99M
Net income from continuing operations
-8.34%-30.8M
-27.98%-117.86M
-9.83%-26.26M
-39.52%-33.19M
-38.41%-29.98M
-25.05%-28.43M
-33.67%-92.09M
-31.00%-23.91M
-28.21%-23.79M
-17.90%-21.66M
Depreciation and amortization
12.66%943K
38.30%3.49M
41.14%892K
-239.86%-1.42M
68.98%3.19M
96.48%837K
76.08%2.53M
60.00%632K
-212.03%-419K
432.77%1.89M
Other non cash items
8.17%1.23M
32.11%4.73M
407.05%4.89M
----
----
23.80%1.14M
12.13%3.58M
7.95%964K
----
----
Change In working capital
-508.57%-4.12M
106.61%650K
-871.29%-779K
344.79%1.27M
113.75%838K
79.63%-677K
-7.09%-9.84M
105.53%101K
53.21%-518K
-659.98%-6.1M
-Change in prepaid assets
-10,242.86%-710K
1,353.33%3.27M
882.42%712K
-67.05%344K
118.08%2.21M
100.40%7K
103.54%225K
88.98%-91K
170.88%1.04M
208.47%1.01M
-Change in payables and accrued expense
-2,720.45%-2.48M
155.83%2.85M
-89.61%172K
185.61%2.66M
114.25%107K
87.81%-88K
175.06%1.11M
2,200.00%1.66M
-14.98%931K
-144.65%-751K
-Change in other current assets
-105.22%-7K
-161.72%-1.89M
-1,444.68%-726K
-65.92%-818K
-936.96%-477K
199.26%134K
-7.93%-721K
86.69%-47K
-1,543.33%-493K
89.20%-46K
-Change in other current liabilities
-26.16%-921K
65.73%-3.58M
33.87%-937K
54.15%-917K
84.17%-999K
-0.41%-730K
-308.52%-10.45M
-97.08%-1.42M
-186.12%-2M
-460.89%-6.31M
Cash from discontinued investing activities
Operating cash flow
-25.54%-30.47M
-17.79%-100.29M
-30.96%-24.03M
-47.59%-27.9M
3.57%-24.1M
-5.96%-24.27M
-23.14%-85.14M
-4.32%-18.35M
-8.99%-18.9M
-50.87%-24.99M
Investing cash flow
Cash flow from continuing investing activities
576.72%43.97M
175.47%71.01M
110.65%10.34M
219.13%40.54M
604.77%13.64M
192.10%6.5M
-2.66%-94.09M
-1,530.04%-97.04M
249.68%12.7M
96.45%-2.7M
Net PPE purchase and sale
-21.28%-114K
87.37%-1.07M
65.42%-111K
-56.04%-465K
93.16%-399K
95.33%-94K
-117.31%-8.46M
72.52%-321K
53.14%-298K
-534.60%-5.83M
Net investment purchase and sale
568.80%44.09M
184.17%72.08M
110.80%10.45M
215.39%41M
348.50%14.04M
230.69%6.59M
2.42%-85.63M
-1,921.21%-96.72M
265.61%13M
104.17%3.13M
Cash from discontinued investing activities
Investing cash flow
576.72%43.97M
175.47%71.01M
110.65%10.34M
219.13%40.54M
604.77%13.64M
192.10%6.5M
-2.66%-94.09M
-1,530.04%-97.04M
249.68%12.7M
96.45%-2.7M
Financing cash flow
Cash flow from continuing financing activities
-96.19%96K
-97.49%2.94M
-99.98%25K
-95.68%176K
-63.91%218K
1,159.50%2.52M
-49.71%117.14M
36,467.10%112.26M
1,927.36%4.08M
235.73%604K
Net common stock issuance
-92.32%278K
-96.05%4.58M
-100.01%-15K
-89.79%392K
14.88%579K
--3.62M
-38.70%115.98M
11,163,100.00%111.63M
--3.84M
--504K
Proceeds from stock option exercised by employees
52.85%-182K
-179.23%-923K
-93.66%40K
-192.31%-216K
-461.00%-361K
-293.00%-386K
110.67%1.17M
104.87%631K
16.42%234K
284.62%100K
Net other financing activities
----
---717K
--0
--0
--0
---717K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-96.19%96K
-97.49%2.94M
-99.98%25K
-95.68%176K
-63.91%218K
1,159.50%2.52M
-49.71%117.14M
36,467.10%112.26M
1,927.36%4.08M
235.73%604K
Net cash flow
Beginning cash position
-43.82%33.77M
-50.81%60.12M
-24.99%47.44M
-47.03%34.63M
--44.87M
-50.81%60.12M
143.95%122.21M
-56.52%63.24M
-61.79%65.37M
----
Current changes in cash
189.20%13.6M
57.57%-26.35M
-337.87%-13.67M
703.01%12.81M
---10.24M
---15.25M
-186.10%-62.1M
86.57%-3.12M
91.71%-2.13M
----
End cash Position
5.59%47.38M
-43.82%33.77M
-43.82%33.77M
-24.99%47.44M
--34.63M
--44.87M
-50.81%60.12M
-50.81%60.12M
-56.52%63.24M
----
Free cash flow
-25.52%-30.58M
-8.28%-101.36M
-29.30%-24.14M
-47.72%-28.36M
20.52%-24.5M
2.22%-24.36M
-28.16%-93.61M
0.47%-18.67M
-6.79%-19.2M
-76.30%-30.82M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -25.54%-30.47M-17.79%-100.29M-30.96%-24.03M-47.59%-27.9M3.57%-24.1M-5.96%-24.27M-23.14%-85.14M-4.32%-18.35M-8.99%-18.9M-50.87%-24.99M
Net income from continuing operations -8.34%-30.8M-27.98%-117.86M-9.83%-26.26M-39.52%-33.19M-38.41%-29.98M-25.05%-28.43M-33.67%-92.09M-31.00%-23.91M-28.21%-23.79M-17.90%-21.66M
Depreciation and amortization 12.66%943K38.30%3.49M41.14%892K-239.86%-1.42M68.98%3.19M96.48%837K76.08%2.53M60.00%632K-212.03%-419K432.77%1.89M
Other non cash items 8.17%1.23M32.11%4.73M407.05%4.89M--------23.80%1.14M12.13%3.58M7.95%964K--------
Change In working capital -508.57%-4.12M106.61%650K-871.29%-779K344.79%1.27M113.75%838K79.63%-677K-7.09%-9.84M105.53%101K53.21%-518K-659.98%-6.1M
-Change in prepaid assets -10,242.86%-710K1,353.33%3.27M882.42%712K-67.05%344K118.08%2.21M100.40%7K103.54%225K88.98%-91K170.88%1.04M208.47%1.01M
-Change in payables and accrued expense -2,720.45%-2.48M155.83%2.85M-89.61%172K185.61%2.66M114.25%107K87.81%-88K175.06%1.11M2,200.00%1.66M-14.98%931K-144.65%-751K
-Change in other current assets -105.22%-7K-161.72%-1.89M-1,444.68%-726K-65.92%-818K-936.96%-477K199.26%134K-7.93%-721K86.69%-47K-1,543.33%-493K89.20%-46K
-Change in other current liabilities -26.16%-921K65.73%-3.58M33.87%-937K54.15%-917K84.17%-999K-0.41%-730K-308.52%-10.45M-97.08%-1.42M-186.12%-2M-460.89%-6.31M
Cash from discontinued investing activities
Operating cash flow -25.54%-30.47M-17.79%-100.29M-30.96%-24.03M-47.59%-27.9M3.57%-24.1M-5.96%-24.27M-23.14%-85.14M-4.32%-18.35M-8.99%-18.9M-50.87%-24.99M
Investing cash flow
Cash flow from continuing investing activities 576.72%43.97M175.47%71.01M110.65%10.34M219.13%40.54M604.77%13.64M192.10%6.5M-2.66%-94.09M-1,530.04%-97.04M249.68%12.7M96.45%-2.7M
Net PPE purchase and sale -21.28%-114K87.37%-1.07M65.42%-111K-56.04%-465K93.16%-399K95.33%-94K-117.31%-8.46M72.52%-321K53.14%-298K-534.60%-5.83M
Net investment purchase and sale 568.80%44.09M184.17%72.08M110.80%10.45M215.39%41M348.50%14.04M230.69%6.59M2.42%-85.63M-1,921.21%-96.72M265.61%13M104.17%3.13M
Cash from discontinued investing activities
Investing cash flow 576.72%43.97M175.47%71.01M110.65%10.34M219.13%40.54M604.77%13.64M192.10%6.5M-2.66%-94.09M-1,530.04%-97.04M249.68%12.7M96.45%-2.7M
Financing cash flow
Cash flow from continuing financing activities -96.19%96K-97.49%2.94M-99.98%25K-95.68%176K-63.91%218K1,159.50%2.52M-49.71%117.14M36,467.10%112.26M1,927.36%4.08M235.73%604K
Net common stock issuance -92.32%278K-96.05%4.58M-100.01%-15K-89.79%392K14.88%579K--3.62M-38.70%115.98M11,163,100.00%111.63M--3.84M--504K
Proceeds from stock option exercised by employees 52.85%-182K-179.23%-923K-93.66%40K-192.31%-216K-461.00%-361K-293.00%-386K110.67%1.17M104.87%631K16.42%234K284.62%100K
Net other financing activities -------717K--0--0--0---717K----------------
Cash from discontinued financing activities
Financing cash flow -96.19%96K-97.49%2.94M-99.98%25K-95.68%176K-63.91%218K1,159.50%2.52M-49.71%117.14M36,467.10%112.26M1,927.36%4.08M235.73%604K
Net cash flow
Beginning cash position -43.82%33.77M-50.81%60.12M-24.99%47.44M-47.03%34.63M--44.87M-50.81%60.12M143.95%122.21M-56.52%63.24M-61.79%65.37M----
Current changes in cash 189.20%13.6M57.57%-26.35M-337.87%-13.67M703.01%12.81M---10.24M---15.25M-186.10%-62.1M86.57%-3.12M91.71%-2.13M----
End cash Position 5.59%47.38M-43.82%33.77M-43.82%33.77M-24.99%47.44M--34.63M--44.87M-50.81%60.12M-50.81%60.12M-56.52%63.24M----
Free cash flow -25.52%-30.58M-8.28%-101.36M-29.30%-24.14M-47.72%-28.36M20.52%-24.5M2.22%-24.36M-28.16%-93.61M0.47%-18.67M-6.79%-19.2M-76.30%-30.82M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg